We provide 1 form of Pomalidomide
Pomalidomide
19171-19-8
|
273.075
|
-0.189
Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. It is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib.
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline | 3-amino-N-(2,6-dioxo-3-piperidinyl) phthalimide | 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | CC-4047 | Pom | Pomalyst | pomalidomide
Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. It is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib.
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline | 3-amino-N-(2,6-dioxo-3-piperidinyl) phthalimide | 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | CC-4047 | Pom | Pomalyst | pomalidomide
$19/5 mg
(EBC)
1
We provide 0 compound for Pomalidomide